Table 2.
Results of L 9 (3 4 ) orthogonal experiment of prescription
| Levels |
A |
B |
C |
D |
Encapsulation efficiency (%) |
|---|---|---|---|---|---|
| Cholesterol/phospholipids (mg/mg) | Emodin dosage (mg) | PH value of PBS | Ether volume (ml) | ||
| 1 |
1 |
1 |
1 |
1 |
45.56 |
| 2 |
1 |
2 |
2 |
2 |
53.12 |
| 3 |
1 |
3 |
3 |
3 |
61.34 |
| 4 |
2 |
1 |
2 |
3 |
58.91 |
| 5 |
2 |
2 |
3 |
1 |
70.78 |
| 6 |
2 |
3 |
1 |
2 |
63.71 |
| 7 |
3 |
1 |
3 |
2 |
64.48 |
| 8 |
3 |
2 |
1 |
3 |
52.01 |
| 9 |
3 |
3 |
2 |
1 |
48.91 |
| K1 |
53.34 |
56.32 |
53.76 |
55.01 |
|
| K2 |
64.47 |
58.64 |
53.65 |
60.44 |
|
| K3 |
55.13 |
57.99 |
65.53 |
57.42 |
|
| R | 11.13 | 2.32 | 11.89 | 5.35 |